• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis.

作者信息

Orozco L C, Quintana F O, Beltrán R M, de Moreno I, Wasserman M, Rodriguez G

出版信息

Tubercle. 1986 Jun;67(2):91-7. doi: 10.1016/0041-3879(86)90002-4.

DOI:10.1016/0041-3879(86)90002-4
PMID:3775869
Abstract

Liposomes loaded with rifampicin and isoniazid were used experimentally to treat mice with severe tuberculosis. The animals were distributed in four groups. The control group and the group treated with unloaded liposomes showed the severest disease. Both groups showed the lowest accumulated survival, about 50% after 30 days. The numbers of colony-forming-units (CFU) and root specific lung weight (RSLW) were the highest and the histopathology of the lung showed marked diffuse lesions. However, the group treated with unloaded liposomes showed significantly higher growth of M. tuberculosis compared with the control. The group treated with drug and drug loaded liposomes showed a higher survival, about 85% after 30 days, and the lowest values of CFU and RSLW. The lung histology revealed considerably less inflammation which was focal. The parameters evaluated indicated a significantly better response in the group of animals treated with rifampicin and isoniazid entrapped in liposomes.

摘要

相似文献

1
The use of rifampicin and isoniazid entrapped in liposomes for the treatment of Murine tuberculosis.
Tubercle. 1986 Jun;67(2):91-7. doi: 10.1016/0041-3879(86)90002-4.
2
Comparative efficacy of daily and intermittent chemotherapy with combinations of rifampicin and isoniazid in chronic murine tuberculosis, with particular reference to the prevention of relapses.利福平与异烟肼联合用药时每日化疗与间歇化疗在慢性鼠结核病中的疗效比较,尤其涉及复发的预防。
Arzneimittelforschung. 1973 Oct;23(10):1465-6.
3
Curative effect of a course of monotherapy with rifampicin, isoniazid or streptomycin subsequent to combination treatment in murine tuberculosis.在小鼠结核病联合治疗后,使用利福平、异烟肼或链霉素进行一个疗程单一疗法的疗效。
Arzneimittelforschung. 1973 Oct;23(10):1462-4.
4
Chemotherapeutic activity against murine tuberculosis of once weekly administered drugs (isoniazid and rifampicin) encapsulated in liposomes.每周给药一次的包裹于脂质体中的药物(异烟肼和利福平)对小鼠结核病的化疗活性。
Int J Antimicrob Agents. 2002 Oct;20(4):301-4. doi: 10.1016/s0924-8579(02)00175-9.
5
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.使用载有利福平的缓释微球与异烟肼口服给药联合治疗结核病。
Antimicrob Agents Chemother. 2001 Jun;45(6):1637-44. doi: 10.1128/AAC.45.6.1637-1644.2001.
6
Liposome-based antitubercular drug therapy in a guinea pig model of tuberculosis.基于脂质体的抗结核药物疗法在豚鼠结核病模型中的应用
Int J Antimicrob Agents. 2004 Apr;23(4):414-5. doi: 10.1016/j.ijantimicag.2004.01.002.
7
Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.
Indian J Med Res. 1998 Oct;108:115-9.
8
Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
Chemotherapy. 1974;20(3):183-200. doi: 10.1159/000221808.
9
Treatment of pulmonary tuberculosis with short course isoniazid-rifampicin regimen compared with standard regimen in ambulatory pediatric clinic.门诊儿科诊所中短程异烟肼-利福平方案与标准方案治疗肺结核的比较
Paediatr Indones. 1983 Nov-Dec;23(11-12):240-9.
10
Influence of immunosuppression on the action of antimycobacterial drugs in experimental tuberculosis. I. Effects of isoniazid, rifampicin and streptomycin on the survival of tuberculous mice immunosuppressed by azathioprine (Imuran).免疫抑制对实验性结核病中抗分枝杆菌药物作用的影响。I. 异烟肼、利福平及链霉素对受硫唑嘌呤(依木兰)免疫抑制的结核小鼠存活情况的影响
Chemotherapy. 1976;22(6):353-61. doi: 10.1159/000221947.

引用本文的文献

1
Liposome-Encapsulated Antibiotics for the Therapy of Mycobacterial Infections.用于治疗分枝杆菌感染的脂质体包封抗生素
Antibiotics (Basel). 2025 Jul 20;14(7):728. doi: 10.3390/antibiotics14070728.
2
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.用于结核病治疗的先进药物输送和治疗策略。
J Nanobiotechnology. 2023 Nov 9;21(1):414. doi: 10.1186/s12951-023-02156-y.
3
Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model.
含利福平的可吸入聚乳酸-羟基乙酸共聚物微球用于治疗结核病:在传染病模型中的筛选
Pharm Res. 2001 Sep;18(9):1315-9. doi: 10.1023/a:1013094112861.
4
Treatment of tuberculosis using a combination of sustained-release rifampin-loaded microspheres and oral dosing with isoniazid.使用载有利福平的缓释微球与异烟肼口服给药联合治疗结核病。
Antimicrob Agents Chemother. 2001 Jun;45(6):1637-44. doi: 10.1128/AAC.45.6.1637-1644.2001.
5
Efficacy of microencapsulated rifampin in Mycobacterium tuberculosis-infected mice.微囊化利福平对结核分枝杆菌感染小鼠的疗效
Antimicrob Agents Chemother. 1999 May;43(5):1144-51. doi: 10.1128/AAC.43.5.1144.
6
Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages.利用微球技术将利福平靶向递送至结核分枝杆菌感染的巨噬细胞。
Antimicrob Agents Chemother. 1998 Oct;42(10):2682-9. doi: 10.1128/AAC.42.10.2682.
7
Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice.肺特异性隐形脂质体包裹的异烟肼和利福平对小鼠结核分枝杆菌感染的治疗效果。
Antimicrob Agents Chemother. 1997 Jun;41(6):1211-4. doi: 10.1128/AAC.41.6.1211.
8
Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice.携带促吞噬素的脂质体作为利福平载体用于小鼠结核病治疗
Antimicrob Agents Chemother. 1994 Mar;38(3):588-93. doi: 10.1128/AAC.38.3.588.
9
Enhanced effect of liposome-encapsulated amikacin on Mycobacterium avium-M. intracellulare complex infection in beige mice.脂质体包裹的阿米卡星对米色小鼠鸟分枝杆菌-胞内分枝杆菌复合感染的增强作用。
Antimicrob Agents Chemother. 1988 Sep;32(9):1404-11. doi: 10.1128/AAC.32.9.1404.
10
Liposome-encapsulated ampicillin against Listeria monocytogenes in vivo and in vitro.脂质体包裹的氨苄西林对单核细胞增生李斯特菌的体内外作用
Infection. 1988;16 Suppl 2:S165-70. doi: 10.1007/BF01639742.